Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_4

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis

NCT03132623
unknownphase_4

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis

NCT03134443
unknownphase_4

A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

NCT03132610

Clinical Trials (3)

Showing 3 of 3 trials
NCT03132623Phase 4

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis

Unknown
NCT03134443Phase 4

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis

Unknown
NCT03132610Phase 4

A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3